Overview

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Africa, Asia, Europe and South America. This trial is designed to show the effect of treatment with liraglutide added to existing glimepiride and metformin combination therapy and to compare it with the effects of insulin glargine added to combination therapy of glimepiride and metformin.
Phase:
Phase 3
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Glimepiride
Insulin
Insulin Glargine
Liraglutide
Metformin